Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy to improve access and foster price competition for drugs that face inadequate generic competition - FDA Press Releases

FDA announces new draft guidance titled, Competitive Generic Therapies, to help provide even greater clarity to industry about the CGT pathway.

from Food and Drug Administration--Press Releases http://bit.ly/2DIba6x
via IFTTT